Abstract-The single dose suppression test was applied to estimating addiction liabili ty of compounds in rats. Morphine at a dose of 50 mg/kg was chronically admin istered twice daily for more than 12 weeks, and the body wt. loss following morphine withdrawal was measured for 24 hr as a parameter of abstinence syndrome. A test compound was administered to the morphine withdrawn rats and physical dependence liability was determined from the increase in body wt. The results of narcotic anal gesics in this method coincided well with those seen in monkeys, however, rats ap peared to be particularly sensitive to morphine-like narcotics. Narcotic antagonists, nalorphine and pentazocine, produced a severe abstinence syndrome, and antipyretics, tranquilizers, hypnotics and anti histaminics had no influence on body wt. loss in the morphine addicted rats. Thus, the single dose suppression test in rats can be useful in detecting physical dependence liability of new compounds, especially mor phine-like analgesics.
The gross behavioral observation technique in monkeys described by Seevers and Deneau (1) is widely used to evaluate the physical dependence liability of various anal gesic compounds. This method includes a) single dose suppression test, b) 24 hr sub stitution test and c) primary physical dependence test.
On the other hand, the method for determining physical dependence liability in mice (2) (3) (4) (5) (6) and rats (7) (8) (9) (10) (11) (12) (13) (14) (15) has also been studied by many investigators but methods have yet to be established. For example, Martin et al. (12) observed the gross behavioral changes caused by morphine withdrawal in chronically morphine-treated rats. Buckett et al. (13) and Lorenzetti et al. (14, 15) , utilizing the primary abstinence syn drome described by Martin et al. (12) , found that the rats could be utilized to predict ad diction liability of several classes of morphine-like compounds in a characteristic and re producible manner by the single dose suppression technique.
In this study, the author attempted to establish a simple and objective method for evaluating physical dependence liability of various narcotic analgesics by modifying the technique described by Buckett et al. (13) and Lorenzetti et al. (14, 15) .
MATERIALS AND METHODS
Male Wistar strain rats, weighing 110-130g at the beginning of experiments, were used. Throughout the experiments, all animals were housed in individual cages, with wire mesh walls. Food and water were provided ad lib in the home cages.
The rats were administered morphine at a dose of 30 mg/kg s.c. twice daily at 9:00 a.m. and 5: 00 p.m. during the first wk. From the second wk., the dose of morphine was increased to 50 mg,/kg s.c. and body wt. was measured daily at 9:00 a.m. Rats on morphine injections for more than 12 wk. were used for evaluation of physical depend ence liability. In the single dose suppression test, the morphine-treated rats were with drawn from morphine for one day (usually Sunday) and rats in which an apparent 30 g decrease in body wt. or more following morphine withdrawal were selected.
Test compounds were administered s.c. instead of morphine at 9: 00 a.m. on the next day, i.e. 24 hr after morphine withdrawal, and changes iii body wt. as well as behavior were observed every 2 hr until 5: 00 p.m.
Morphine was injected again at 5: 00 p.m.
This test schedule was repeated every wk. and the physical dependence liability of narcotics or new analgesic compounds was determined from the changes in body wt. gain.
The physical dependence liability was estimated, by comparing the mean body wt. All drugs were dissolved in water and injected s.c. at a fixed volume of 5 ml/kg except for meprobamate, which was suspended in a 0.5% carboxymethylcellulose solution and injected i.p.
Rats of the control group were given physiological saline.
RESULTS

Changes in body wt. following withdrawal
Although the rats given morphine exerted a marked sedation for an initial period, such behavior gradually disappeared after 2-3 wk. and hyperactivity, gnawing and cata lepsy were obvious after morphine administration. Table I shows body wt. changes following morphine withdrawal. A decrease in body wt. after sudden morphine withdrawal was observed and the changes were significant in rats on morphine for more than 12 wk. During the with drawal period, the rats displayed sedation, diarrhea and loss of appetite, but wet shaking and writhing were absent. a) Length in wk. of chronic morphine administration. Ten rats used in this experiment were withdrawn from morphine at the end of each wk. b) Body wt. was measured at 9 : 00 a.m. before morphine withdrawal. c) Body wt. was measured at 9 : 00 a.m. after morphine withdrawal for 24 hr. d) Body wt. loss induced by morphine withdrawal (b-c). Single dose suppression test Rats which had been withdrawn from morphine for 24 hr were sedated but remained responsive to stimuli.
Following a single administration of morphine at doses of 10-50 mg/kg, these rats walked around in the cages and occasionally assumed cataleptic posture. The rats on morphine consumed food and water voraciously. Accompanying these behavioral changes, body wt. markedly increased by approx. 60, 70 and 100 % for 10, 20 and 50 mg/kg respectively at the peak of 4-6 hr after morphine injection.
As shown in Fig. 1 , meperidine and codeine displayed almost the same results as mor phine, although the increase in body wt. was less in degree than morphine. Body wt. gain of rats treated with d-propoxyphene at doses of 20-50 mg/kg was approx. the same as that seen with meperidine and codeine, and increase in spontaneous activity was slightly observed.
Results with other various drugs are shown in Table 3 . No suppression of abstinence syndrome was seen in the groups of ethoheptazine or aminopyrine administered rats and the change in body wt. was not significantly different from that seen in the control. Nalorphine at doses of 5-50 mg/kg precipitated marked writhing, shivering and scratch ing the floor of the wire cage 10-15 min after administration, and these symptoms lasted for approx. 60 min. Accompanying the development of abstinence syndrome, body wt. loss was observed after only 8 hr (Fig. 1) . Signs of abstinence following administration of pentazocine at doses of 20-50 mg/kg were less potent than in the case of nalorphine at a dose of 50 mg/kg. Body wt. decreased slightly within 2 hr, thereafter increasing inversely after 6-8 hr (Fig. 1) . When given chlorpromazine and meprobamate, the morphine-treated rats showed sedation and muscle relaxation, however body wt. did not change as compared with the control group during the test period. Cyproheptadine did not influence body wt. or the abstinence syndrome. According to the single dose suppression test in which body wt. changes were used as a parameter, the physical dependence liability of morphine was high, while meperidine, codeine and d-propoxyphene were approx. half as potent.
As nalorphine, a potent narcotic antagonist produced a severe abstinence syndrome in the morphine-withdrawn rats, the physical dependence liability utilizing the single dose suppression test could not be evaluated. DISCUSSION In developing new analgesics, the problem of whether or not the compounds have a physical dependence liability should be given consideration. A number of investigators have utilized available physical dependence tests in various animal species with varying degrees of reliability, especially with relativity to humans.
Monkeys have been commonly used for the evaluation of physical dependence, as there is a better quantitative correlation to humans than is seen in other species (1).
Kaymakcalan and Woods (7) and others (8) (9) (10) (11) (12) (13) (14) (15) reported that the abstinence syndrome was observed following morphine withdrawal or nalorphine administration in chronic morphine-treated rats. The direct injection technique, however, is unsuitable for pre linminary screening tests used in evaluating physical dependence liability at an early stage in developing new analgesics since this method is neither economical of time nor materials.
The author attempted to overcome these drawbacks.
Body wt. loss induced by withdrawal or nalorphine injection after successive morphine administration in rats is regarded as an abstinence syndrome related to physical depend ence (8) (9) (10) .
A fairly constant body wt. loss was seen with withdrawal after a chronic morphine administration of more than 12 wk.
Rats treated with morphine at a daily dose of 100 mg/kg did not demonstrate the primary abstinence syndrome such as wet shaking, writhing, squealing, teeth chattering, urination and erection described by Martin et al. (12) following morphine withdrawal for 24-72 hr, however body wt. loss was quite apparent in these rats. Body wt. loss is regarded as a more quantitative and objective parameter of abstinence syndrome than the other symptoms. Table 3 summarizes the physical dependence lia bility of various drugs obtained from the single dose suppression test in rats and is com pared with that in monkeys (1, 14, 17, (23) (24) (25) . Narcotics such as morphine, meperidine and codeine caused a significant increase in body wt. of morphine-treated rats.
It was suggested that the physical dependence liability of morphine is high while that of meperidine and codeine, intermediate. These results coincided fairly well with those in monkeys. d-Propoxyphene is shown to have a very low or negligible addiction liability in mice (6), monkeys (1, 16) and humans (18) . The World Health Organization is of the opinion that there is no need for narcotics control of d-propoxyphene (19) , however in the experiment herein d-propoxyphene showed intermediate addiction liability compar able with meperidine and codeine.
Lorenzetti et al. (14, 15) reported that d-propoxyphene precipitated codeine-like physi cal dependence liability by using the method of scoring withdrawal syndrome induced by levallorphan in rats. Nalorphine and pentazocine showed no physical dependence liability in the single dose suppression test in monkeys as these drugs produce a severe abstinence syndrome.
In the present experiments, administration of nalorphine at doses of 5-10 mg/kg caused a severe abstinence syndrome and a marked body wt. loss. On the other hand, pentazocine caused an increase in body wt. after appearance of the abstinence syndrome, therefore, addiction liability was regarded as being very low.
Analgesic activity of TA-306 (20) and TA-404 (21) 
